Navigation Links
Medarex to Present at the Susquehanna Financial Group Healthcare Conference
Date:2/28/2008

PRINCETON, N.J., Feb. 28 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today that it is scheduled to present at the Susquehanna Financial Group Second Annual SIGnificant Investment Options in Healthcare Conference at 3:00 p.m. ET on Wednesday, March 5, 2008, in New York. The event will be webcast live and will be available in the Investor Relations section of the Medarex website at http://www.medarex.com. An archived edition of the presentation will be available following the event.

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. Over forty of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with seven of the most advanced product candidates currently in Phase 3 clinical trials or the subject of regulatory applications for marketing authorization. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its website at http://www.medarex.com.

Medarex(R), the Medarex logo and UltiMAb(R) are registered trademarks of Medarex, Inc. All rights are reserved.


'/>"/>
SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008
2. Medarex Announces Completion of Sale of Shares in Genmab A/S
3. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
4. Medarex Announces Election of Marc Rubin as New Board Member
5. Medarex to Present at the UBS Global Life Sciences Conference
6. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
7. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
8. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
9. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
10. InterMune to Present at the SIGnificant Options in Healthcare Conference
11. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... Pune, India , January 12, 2017 A new ... Type and End Users - Global Opportunity Analysis and Industry Forecast, 2014-2022," projects that ... $2,921 million in 2015, growing at a CAGR of 15.07% during the forecast period. ... ... Market Research Logo ...
(Date:1/12/2017)... MD (PRWEB) , ... January ... ... the market’s rapid adoption of Limfinity® Cloud, RURO has enhanced the platform ... cross-continent user groups, federated login, rapid data searching, and more. In addition ...
(Date:1/11/2017)... Angeles, California (PRWEB) , ... January 11, 2017 ... ... approach to support fertility specialists with accurate and reliable preimplantation genetic screening (PGS). ... we have achieved excellent results,” says Ovation Fertility Genetics Scientific Director Amy ...
(Date:1/11/2017)... ... January 11, 2017 , ... Photonics industry and STEM advocates ... commending the U.S. Congress and President Obama for their recognition of the importance ... American Innovation and Competitiveness Act (AICA). , The language of the act (S. ...
Breaking Biology Technology:
(Date:1/6/2017)...  Delta ID Inc., a leader in consumer-grade iris ... at CES® 2017. Delta ID has collaborated with Gentex ... use of iris scanning as a secure, reliable and ... a car, and as a way to elevate the ... Delta ID and Gentex will demonstrate (booth #7326 LVCC) ...
(Date:12/22/2016)... , Dec. 20, 2016  As part of its longstanding ... leading personal genetics company, recently released its latest children,s book, ... The book focuses on the topics of inheritance and variation ... Standards (NGSS) taught in elementary school classrooms in the US. ... series by illustrator Ariana Killoran , whose previous book ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016 /PRNewswire/ ... que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que ... de tumor en 2017, con múltiples sitios previstos a lo largo ... ... en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que ...
Breaking Biology News(10 mins):